Sentence examples for insufficient scientific data from inspiring English sources

In March the International Court of Justice ruled that Japan had produced insufficient scientific data to justify the killing of whales for "research" and put an immediate end to its hunts in the Antarctic.

"There's insufficient scientific data to recommend for or against A.E.D.'s in the home". Critics like Dr. Arthur Caplan, director of the Center for Bioethics at the University of Pennsylvania, say that marketing such devices preys on the fears of basically healthy people, the vast majority facing little risk of sudden heart stoppage.

Critics have raised questions about not only the consent process, conflicts of interest, and inappropriate publicity, but also the basic science of the research, contending there was insufficient scientific data to support the use of the Jarvik heart as a permanent device in humans.

Insufficient scientific data are available to define quality standards as for A. mellifera honey.

When there is evidence that a risk to human health exists but scientific data are insufficient or incomplete, the Codex Alimentarius Commission should not proceed to elaborate a standard but should consider elaborating a related text, such as a code of practice, provided that such a text would be supported by the available scientific evidence.

However, the mechanisms behind the degradation processes remain poorly understood due to scarce baseline data and insufficient scientific research.

EFSA spokeswoman Lucia de Luca says insufficient scientific evidence - or inadequate information - is to blame for the most of the rejected claims.

In terms of prioritization, it was found that, out of this number, 320 substances showed evidence or potential evidence for ED effects, while in total, 109 substances were not retained in the priority list, either due to insufficient data on ED effects or insufficient scientific evidence.

The study found "an absence of scientific data demonstrating the effectiveness of cannabis products" and warned of "insufficient information on [the drug's] safety during long-term use for the treatment of chronic medical conditions".

Data 'owners' cite a spectrum of reasons: fear of activists or biopiracy; concern about insufficient data quality; a desire for economic return, or to control access and use of the scientific data; and the cost of digitizing collection data, on the order of US$1 10 per specimen [ 34], although initiatives have begun to reduce these costs significantly (http://beyondthebox.aibs.org/).org/

The scientific data are heartbreaking.